Sentences with phrase «in regenerative medicine research»

During his tenure at the University of Florida, he was active in the feral cat spay and neuter program, developed an interest in orthopedic and neurosurgery for cats and dogs and participated in regenerative medicine research at the College of Medicine.

Thanks to a chance discovery, researchers have found a more efficient way to create induced pluripotent stem cells (iPSCs), which are widely used in regenerative medicine research and drug development.

Not exact matches

An original co-founder of MaRS, U of T has chosen the site for its renowned research teams working in drug discovery, regenerative medicine, infectious diseases and advanced computing.

The AOKI FOUNDATION's primary goal is supporting organizations in the brain science and research areas with a specific focus on regenerative medicine and brain preservation.

The new tower will also host the Medicine by Design initiative, set to become a leading centre in regenerative medicine at the University of Toronto with the federal government committing $ 114 - million for this project through the Canada First Research ExcellenMedicine by Design initiative, set to become a leading centre in regenerative medicine at the University of Toronto with the federal government committing $ 114 - million for this project through the Canada First Research Excellenmedicine at the University of Toronto with the federal government committing $ 114 - million for this project through the Canada First Research Excellence Fund.

We have some of the world's leading hospitals and research in regenerative medicine.

At GFI, David combines his background in plant biology and regenerative medicine to help companies and academic research institutions accelerate the development of plant - based and clean meat alternatives to animal products.

Throughout 2017, ongoing clinical trials in regenerative medicine using cord blood have offered hope to families facing life - changing medical conditions, such as cerebral palsy and autism.1 For some of these families, banking their baby's cord blood with ViaCord gave them the opportunity to participate in this groundbreaking research.

The collaborative study was developed from a meeting last August of sports medicine clinicians, researchers and a bioethicist to understand the current evidence risks and rewards and future directions of research and clinical practice for regenerative medicine therapies in youth sports.

It can be used in embryonic stem cell research, or in regenerative medicine where it is sometimes referred to as «therapeutic cloning.»

In a groundbreaking study that provides scientists with a critical new understanding of stem cell development and its role in disease, UCLA researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first - of - its - kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embryIn a groundbreaking study that provides scientists with a critical new understanding of stem cell development and its role in disease, UCLA researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first - of - its - kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embryin disease, UCLA researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first - of - its - kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embryin the embryo.

«It's a stellar piece of work — the fact they were able to achieve the precise shape they need is impressive,» says Charles Vacanti, director of the Laboratory for Tissue Engineering and Regenerative Medicine at Brigham and Women's Hospital in Boston, who did not take part in this research.

«Despite new therapies, it's virtually inevitable that a patient with multiple myeloma will experience relapse of the disease at some point,» said senior author Catriona Jamieson, MD, PhD, professor of medicine, Koman Family Presidential Endowed Chair in Cancer Research and chief of the Division of Regenerative Medicine at UC San Diego School of Mmedicine, Koman Family Presidential Endowed Chair in Cancer Research and chief of the Division of Regenerative Medicine at UC San Diego School of MMedicine at UC San Diego School of MedicineMedicine.

If you are a biomedical engineer developing scaffolds to grow cartilage for regenerative medicine, you are unlikely to publish in top biology journals because your research is not viewed as fundamental, Viceconti says.

This work provides us with a promising new tool in the CRISPR toolbox,» said author Dr. Eric Olson, Chairman of Molecular Biology, Co-Director of the UT Southwestern Wellstone Muscular Dystrophy Cooperative Research Center, and Director of the Hamon Center for Regenerative Science and Medicine.

Now commander of the Dental and Trauma Research Detachment at the U.S. Army Institute of Surgical Research in San Antonio, he has brought the best and brightest minds of regenerative and transplant medicine to the task of healing some of the most grievous wounds of modern warfare.

But a number of the invited speakers, including Alan Trounson, president of the California Institute for Regenerative Medicine in San Francisco, and keynote speaker George Daley, a stem - cell scientist at Children's Hospital Boston in Massachusetts, are involved in research using human embryonic stem cells, which the Catholic Church considers unethical.

The country has begun to regain confidence from a series of successful research projects, and is ranked in the world's top ten for stem - cell and regenerative medicine research in terms of number and quality of publications.

The U.S. Department of Defense, which received a congressional windfall of $ 80 million to research regenerative medicine in 2008, is funding a team of scientists based at the University of Pittsburgh's McGowan Institute for Regenerative Medicine to oversee an 80 - patient study of ECM at five iregenerative medicine in 2008, is funding a team of scientists based at the University of Pittsburgh's McGowan Institute for Regenerative Medicine to oversee an 80 - patient study of ECM at five instimedicine in 2008, is funding a team of scientists based at the University of Pittsburgh's McGowan Institute for Regenerative Medicine to oversee an 80 - patient study of ECM at five iRegenerative Medicine to oversee an 80 - patient study of ECM at five instiMedicine to oversee an 80 - patient study of ECM at five institutions.

The research, published online in the journal Science, is the inaugural paper from UT Southwestern's newly established Hamon Center for Regenerative Science and Medicine, made possible earlier this year by a $ 10 million endowment gift from the Hamon Charitable Foundation.

Lou Gehrig's disease, also known as amyotrophic lateral sclerosis, or ALS, might damage muscle - controlling nerve cells in the brain earlier in the disease process than previously known, according to research from the Cedars - Sinai Board of Governors Regenerative Medicine Institute.

Notably, people who work in regenerative medicine or stem cell research may not in fact consider themselves regenerative medicine specialists.

Yin and other scientists conducting research in the institution's Kathryn W. Davis Center for Regenerative Medicine study tissue repair, regeneration and aging in a diverse range of organisms that have robust mechanisms to repair and regenerate tissue.

«We knew this gene's alteration likely contributed to schizophrenia and we wanted to better understand how,» said Mei, chairman of the Department of Neuroscience and Regenerative Medicine at the Medical College of Georgia at Augusta University, Georgia Research Alliance Eminent Scholar in Neuroscience and a corresponding author of the study in the journal PNAS.

«Our paper is a blueprint of how the cartilage - producing cell, called a chondrocyte, is made and maintained by Sox9,» said He, a postdoctoral research associate in the lab of Andy McMahon, director of the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Researchresearch associate in the lab of Andy McMahon, director of the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell ResearchResearch at USC.

In a boon to stem cell research and regenerative medicine, scientists at Boston Children's Hospital, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston University have created a computer algorithm called CellNet as a «roadmap» for cell and tissue engineering, to ensure that cells engineered in the lab have the same favorable properties as cells in our own bodieIn a boon to stem cell research and regenerative medicine, scientists at Boston Children's Hospital, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston University have created a computer algorithm called CellNet as a «roadmap» for cell and tissue engineering, to ensure that cells engineered in the lab have the same favorable properties as cells in our own bodiein the lab have the same favorable properties as cells in our own bodiein our own bodies.

The multidisciplinary team behind the current study includes world - renowned researchers in the field of regenerative medicine and tissue engineering; Paolo Macchiarini, MD, PhD, Director of the Advanced Center for Regenerative Medicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical Universitregenerative medicine and tissue engineering; Paolo Macchiarini, MD, PhD, Director of the Advanced Center for Regenerative Medicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inmedicine and tissue engineering; Paolo Macchiarini, MD, PhD, Director of the Advanced Center for Regenerative Medicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical UniversitRegenerative Medicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inMedicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical UniversitRegenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inMedicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inResearch Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inMedicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inresearch team at the Kuban State Medical University in Russia.

Dr Stephen Simpson, director of research and programmes at Arthritis Research UK added: «This is exciting, novel work in the field of regenerative medicine, which although in its early experimental stages, could take us a step closer to our ultimate goal of a more effective and much - needed new treatment for the very many people who live with this painful joint conditionresearch and programmes at Arthritis Research UK added: «This is exciting, novel work in the field of regenerative medicine, which although in its early experimental stages, could take us a step closer to our ultimate goal of a more effective and much - needed new treatment for the very many people who live with this painful joint conditionResearch UK added: «This is exciting, novel work in the field of regenerative medicine, which although in its early experimental stages, could take us a step closer to our ultimate goal of a more effective and much - needed new treatment for the very many people who live with this painful joint condition.»

«Implantation to mother's uterus is arguably one of the hardest things we ever have to do in life,» said Ruohola - Baker, University of Washington professor of biochemistry and associate director of the UW Institute for Stem Cell and Regenerative Medicine, who led the research team.

The results obtained in this first flatworm study between Kentucky Space and Tufts University will become the basis for their next phase of research in regenerative medicine.

That is why in recent years, regenerative medicine has been among the most active and well - funded research areas in many developing nations.

Research led by Ed Morrisey, PhD, professor of Medicine and Cell and Developmental Biology in the Perelman School of Medicine, University of Pennsylvania and scientific director of the Penn Institute for Regenerative Medicine, has identified hundreds of these lncRNAs, sometimes called the «genomic dark matter,» that are expressed in developing and adult lungs.

The study was published in the journal PLOS Biology by co-senior author Bennett Novitch, member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and collaborators from the Francis Crick Institute in London, U.K..

In a study led by Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research member Dr. Julian Martinez - Agosto, UCLA scientists have shown that two genes not previously known to be involved with the immune system play a crucial role in how progenitor stem cells are activated to fight infectioIn a study led by Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research member Dr. Julian Martinez - Agosto, UCLA scientists have shown that two genes not previously known to be involved with the immune system play a crucial role in how progenitor stem cells are activated to fight infectioin how progenitor stem cells are activated to fight infection.

Applying a new method that is used mainly in stem - cell research and regenerative medicine, researchers from the Technical University of Munich have now devised a robust intestinal model for molecular research into incretin release in a test tube (in vitro).

The research, done in an animal model, was supported by the National Institutes of Health, the Crohn's and Colitis Foundation, and the Regenerative Engineering and Medicine Center operated by Emory University, Georgia Tech and the University of Georgia.

«The results were remarkable, with significant shrinkage in patient - derived tumors,» said Memarzadeh, who also is an associate professor of obstetrics and gynecology and the director of the G.O. Discovery Laboratory at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and associate professor.

Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are bringing stem cell science funded by the California Institute of Regenerative Medicine (CIRM), the state stem cell agency, directly to patients in two exciting new clinical trials scheduled to begin in early 2014.

«This alternative source of Leydig cells will be of great significance for basic research and provides the attractive prospect of clinical application in the field of regenerative medicine.»

«We concluded that RAC1 regulates lung branching morphogenesis, in part through the so - called canonical Wnt signaling pathway, which leads to the regulation of the transcription of many genes,» said principal investigator Denise Al Alam, PhD, of the Department of Surgery and the Developmental Biology and Regenerative Medicine Program at The Saban Research Institute.

Dr. Lei Li and Dr. Xiang - Dong Sun, Fellows and co-authors and Dr. Lin Mei, chairman of the Department of Neuroscience and Regenerative Medicine at the Medical College of Georgia at Augusta University and Georgia Research Alliance Eminent Scholar in Neuroscience.

On the surface of our numerous star - shaped brain cells called astrocytes, they have found the molecule LRP4 is important in ensuring healthy levels of a brain chemical that enables learning and memory, said Dr. Lin Mei, chairman of the Department of Neuroscience and Regenerative Medicine at the Medical College of Georgia at Augusta University and Georgia Research Alliance Eminent Scholar in Neuroscience.

In the field of iPS cell - based regenerative medicine, advanced research with clinical applications for many organs and tissues, such as the retina, has steadily progressed.

In 5 years as inaugural director of USC's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Pera built a stem cell program spanning basic research to clinicalResearch, Pera built a stem cell program spanning basic research to clinicalresearch to clinical trials.

«I think this is an extremely important — and solid — paper,» says stem cell researcher Robert Lanza, vice president of research and scientific development at Applied Cell Technology, a regenerative medicine company headquartered in Alameda, Calif., who did not take part in the study.

UCLA researchers led by Drs. Peiyee Lee and Richard Gatti at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have used induced pluripotent stem cells (iPSC) to advance disease - in - a-dish modeling of a rare genetic disorder, Ataxia Telangiectasia (A-T).

The study was published in the journal Nature Cell Biology by senior author April Pyle, associate professor of microbiology, immunology and molecular genetics and member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.

«Essentially, they cause acetylcholine to build up in the brain, causing hyperexcitability of neurons as well as the death of some neurons, which leads to inflammation in the brain,» said Ashok K. Shetty, PhD, a professor in the Department of Molecular and Cellular Medicine at the Texas A&M College of Medicine, associate director of the Institute for Regenerative Medicine, research career scientist at the Olin E. Teague Veterans Medical Center, Central Texas Veterans Health Care System and senior author of the paper.

«Our research shows that cells derived from corneal stem cells are attractive candidates for generating corneal cells in the laboratory,» said Alexander Ljubimov, PhD, director of the Eye Program at the Board of Governors Regenerative Medicine Institute and principal investigator on this research study.

Funding for this research came, in part, from the National Institutes of Health (grants EY022611, EY024134 and CA132809) and California Institute for Regenerative Medicine (grant RB2 - 01547).